These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16467261)

  • 1. P450 oxidoreductase deficiency: a new disorder of steroidogenesis.
    Miller WL; Huang N; Pandey AV; Flück CE; Agrawal V
    Ann N Y Acad Sci; 2005 Dec; 1061():100-8. PubMed ID: 16467261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.
    Huang N; Pandey AV; Agrawal V; Reardon W; Lapunzina PD; Mowat D; Jabs EW; Van Vliet G; Sack J; Flück CE; Miller WL
    Am J Hum Genet; 2005 May; 76(5):729-49. PubMed ID: 15793702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antley-Bixler syndrome or POR deficiency?].
    Tomková M; Marohnic CC; Baxová A; Martásek P
    Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes.
    Pandey AV; Flück CE; Huang N; Tajima T; Fujieda K; Miller WL
    Endocr Res; 2004 Nov; 30(4):881-8. PubMed ID: 15666840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
    Miller WL
    Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.
    Scott RR; Gomes LG; Huang N; Van Vliet G; Miller WL
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2318-22. PubMed ID: 17389698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
    Flück CE; Nicolo C; Pandey AV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome.
    Adachi M; Tachibana K; Asakura Y; Yamamoto T; Hanaki K; Oka A
    Am J Med Genet A; 2004 Aug; 128A(4):333-9. PubMed ID: 15264278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.
    Flück CE; Tajima T; Pandey AV; Arlt W; Okuhara K; Verge CF; Jabs EW; Mendonça BB; Fujieda K; Miller WL
    Nat Genet; 2004 Mar; 36(3):228-30. PubMed ID: 14758361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
    Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.
    Sahakitrungruang T; Huang N; Tee MK; Agrawal V; Russell WE; Crock P; Murphy N; Migeon CJ; Miller WL
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4992-5000. PubMed ID: 19837910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations.
    Miller WL
    Trends Endocrinol Metab; 2004 Sep; 15(7):311-5. PubMed ID: 15350602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
    Jin Y; Chen M; Penning TM; Miller WL
    Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
    Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL
    Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of POR mutations and polymorphisms.
    Miller WL; Agrawal V; Sandee D; Tee MK; Huang N; Choi JH; Morrissey K; Giacomini KM
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):174-9. PubMed ID: 21070833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analysis of mutations in P450 oxidoreductase.
    Pandey AV
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1186-91. PubMed ID: 17073782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
    Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.
    Flück CE; Mullis PE; Pandey AV
    Biochem Biophys Res Commun; 2010 Oct; 401(1):149-53. PubMed ID: 20849814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.
    Pandey AV; Kempná P; Hofer G; Mullis PE; Flück CE
    Mol Endocrinol; 2007 Oct; 21(10):2579-95. PubMed ID: 17595315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients.
    Fukami M; Horikawa R; Nagai T; Tanaka T; Naiki Y; Sato N; Okuyama T; Nakai H; Soneda S; Tachibana K; Matsuo N; Sato S; Homma K; Nishimura G; Hasegawa T; Ogata T
    J Clin Endocrinol Metab; 2005 Jan; 90(1):414-26. PubMed ID: 15483095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.